Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum-sensitive Ovarian Cancer

Clinical trial NCT01611558 · COMPLETED

Trial details

NCT number: NCT01611558
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line

Start date: 2012-08-21
Primary completion: 2014-11-03
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.